Anders RF - Search Results

1

Anders RF, Saul A. Anders RF, et al. Parasitol Today. 2000 Oct;16(10):444-7. doi: 10.1016/s0169-4758(00)01784-1. Parasitol Today. 2000. PMID: 11006477 Review.

2

The development of a malaria vaccine.

Pye D, Woodrow G, Saul A, Anders R. Pye D, et al. Australas Biotechnol. 1991 Dec;1(3):151-4. Australas Biotechnol. 1991. PMID: 1367733 Review.

3

A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant.

Saul A, Lawrence G, Allworth A, Elliott S, Anderson K, Rzepczyk C, Martin LB, Taylor D, Eisen DP, Irving DO, Pye D, Crewther PE, Hodder AN, Murphy VJ, Anders RF. Saul A, et al. Among authors: anders rf. Vaccine. 2005 Apr 27;23(23):3076-83. doi: 10.1016/j.vaccine.2004.09.040. Vaccine. 2005. PMID: 15811655 Clinical Trial.

4

Strain-specific humoral response to a polymorphic malaria vaccine.

Flück C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A, Genton B, Felger I. Flück C, et al. Infect Immun. 2004 Nov;72(11):6300-5. doi: 10.1128/IAI.72.11.6300-6305.2004. Infect Immun. 2004. PMID: 15501757 Free PMC article. Clinical Trial.

5

Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.

Sturchler D, Berger R, Rudin C, Just M, Saul A, Rzepczyk C, Brown G, Anders R, Coppel R, Woodrow G, et al. Sturchler D, et al. Am J Trop Med Hyg. 1995 Oct;53(4):423-31. doi: 10.4269/ajtmh.1995.53.423. Am J Trop Med Hyg. 1995. PMID: 7485698 Clinical Trial.

6

Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers.

Lawrence G, Cheng QQ, Reed C, Taylor D, Stowers A, Cloonan N, Rzepczyk C, Smillie A, Anderson K, Pombo D, Allworth A, Eisen D, Anders R, Saul A. Lawrence G, et al. Vaccine. 2000 Mar 17;18(18):1925-31. doi: 10.1016/s0264-410x(99)00444-2. Vaccine. 2000. PMID: 10699342 Clinical Trial.

7

Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea.

Genton B, Al-Yaman F, Anders R, Saul A, Brown G, Pye D, Irving DO, Briggs WR, Mai A, Ginny M, Adiguma T, Rare L, Giddy A, Reber-Liske R, Stuerchler D, Alpers MP. Genton B, et al. Vaccine. 2000 May 22;18(23):2504-11. doi: 10.1016/s0264-410x(00)00036-0. Vaccine. 2000. PMID: 10775784 Clinical Trial.

8

A putative Plasmodium falciparum exported serine/threonine protein kinase.

Kun JF, Hibbs AR, Saul A, McColl DJ, Coppel RL, Anders RF. Kun JF, et al. Among authors: anders rf. Mol Biochem Parasitol. 1997 Mar;85(1):41-51. doi: 10.1016/s0166-6851(96)02805-8. Mol Biochem Parasitol. 1997. PMID: 9108547

9

Selection of an adjuvant for vaccination with the malaria antigen, MSA-2.

Pye D, Vandenberg KL, Dyer SL, Irving DO, Goss NH, Woodrow GC, Saul A, Alving CR, Richards RL, Ballou WR, Wu MJ, Skoff K, Anders RF. Pye D, et al. Among authors: anders rf. Vaccine. 1997 Jun;15(9):1017-23. doi: 10.1016/s0264-410x(96)00289-7. Vaccine. 1997. PMID: 9261951

10

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant.

Saul A, Lawrence G, Smillie A, Rzepczyk CM, Reed C, Taylor D, Anderson K, Stowers A, Kemp R, Allworth A, Anders RF, Brown GV, Pye D, Schoofs P, Irving DO, Dyer SL, Woodrow GC, Briggs WR, Reber R, Stürchler D. Saul A, et al. Among authors: anders rf. Vaccine. 1999 Aug 6;17(23-24):3145-59. doi: 10.1016/s0264-410x(99)00175-9. Vaccine. 1999. PMID: 10462251 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page